Form 8-K - Current report:
SEC Accession No. 0001213900-18-011210
Filing Date
2018-08-15
Accepted
2018-08-15 17:05:53
Documents
1
Period of Report
2018-08-09
Items
Item 4.01: Changes in Registrant's Certifying Accountant

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k042718_actiniumpharma.htm 8-K 19639
  Complete submission text file 0001213900-18-011210.txt   20800
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36374 | Film No.: 181021650
SIC: 2834 Pharmaceutical Preparations